| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer L, Gordon EM, Hornick JL, Du H, Grigorian B, Schmid AN, Hou S, Harris K, Kwiatkowski DJ, et al. -Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101728. PMID 34637337 DOI: 10.1200/JCO.21.01728 |
0.01 |
|
| 2021 |
Morse MA, Chawla SP, Wong TZ, Bruckner HW, Hall FL, Gordon EM. Tumor protein p53 mutation in archived tumor samples from a 12-year survivor of stage 4 pancreatic ductal adenocarcinoma may predict long-term survival with DeltaRex-G: A case report and literature review. Molecular and Clinical Oncology. 15: 186. PMID 34277005 DOI: 10.3892/mco.2021.2348 |
0.01 |
|
| 2021 |
Gordon EM. Lesion-Targeted Anti-Cancer Gene Delivery with Clinical Survival Benefits: A Molecular “Rosetta Stone” for Veterinary Hematology-Oncology and Precision Gene Therapy Biomedical Journal of Scientific & Technical Research. 35. DOI: 10.26717/bjstr.2021.35.005736 |
0.01 |
|
| 2021 |
Gordon E, Dang J, Angel NL, Brigham DA, Ostendorf L, Jafari O, Chawla SP, Hall FL. Control of Metastatic Tumor Growth in a Patient with Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumor (sMPNST) Using the Hope Protocol, an Alternative Treatment Regimen for Cancer Integrative Journal of Medical Sciences. 8. DOI: 10.15342/IJMS.2021.453 |
0.01 |
|
| 2021 |
Chawla NS, Kim T, Sherman T, Dang J, Chua VS, Moradkhani A, Bhuiyan I, Krkyan N, Fernando M, Colletti E, Feske W, Zheng K, Chow WA, Agulnik M, Quon D, ... ... Gordon EM, et al. A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma. Journal of Clinical Oncology. 39: 11567-11567. DOI: 10.1200/JCO.2021.39.15_SUPPL.11567 |
0.01 |
|
| 2020 |
Chawla SP, Chua VS, Kim K, Dy PS, Paz MK, Angel N, Wang K, Moradkhani A, Quon D, Wong S, Jafari O, Gordon EM. The TNT protocol: A phase II study using talimogene laherparepvec (TVEC), nivolumab (N) and trabectedin (T) as first, second/third line therapy for advanced sarcoma, including desmoid tumor and chordoma. Journal of Clinical Oncology. 38: TPS11572-TPS11572. DOI: 10.1200/jco.2020.38.15_suppl.tps11572 |
0.01 |
|
| 2020 |
Gordon EM, Chua-Alcala VS, Kim K, Dy PS, Paz MK, Angel N, Moradkhani A, Quon D, Wong S, Jafari O, Chawla SP. SAINT: Results of an expanded phase II study using safe amounts of ipilimumab (I), nivolumab (N), and trabectedin (T) as first-line treatment of advanced soft tissue sarcoma [NCT03138161]. Journal of Clinical Oncology. 38: 11520-11520. DOI: 10.1200/jco.2020.38.15_suppl.11520 |
0.01 |
|
| 2020 |
Wagner AJ, Ravi V, Riedel RF, Ganjoo KN, Van Tine BA, Chugh R, Cranmer LD, Gordon EM, Hornick JL, Kwiatkowski DJ, Du H, Grigorian B, Schmid AN, Hou S, Harris K, et al. Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT. Journal of Clinical Oncology. 38: 11516-11516. DOI: 10.1200/jco.2020.38.15_suppl.11516 |
0.01 |
|
| 2019 |
Chawla SP, Bruckner H, Morse MA, Assudani N, Hall FL, Gordon EM. A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer. Molecular Therapy Oncolytics. 12: 56-67. PMID 30705966 DOI: 10.1016/J.Omto.2018.12.005 |
0.01 |
|
| 2019 |
Gordon EM, Chawla SP, Hall FL. Survival data following phase 1/2 studies using precision tumor-targeted gene delivery to advanced chemotherapy-resistant malignancies. Journal of Global Oncology. 5: 101-101. DOI: 10.1200/Jgo.2019.5.Suppl.101 |
0.01 |
|
| 2019 |
Chawla SP, Chua-Alcala VS, Kim K, Assudani N, Al-Shihabi A, Moradkhani A, Quon D, Wong S, Tseng WW, Pollack S, Srikureja AM, Jalas J, Jones RL, Gordon EM. The SAINT: Initial results of a phase I/II study of safety/efficacy using safe amounts of ipilimumab, nivolumab, and trabectedin as first-line treatment of advanced soft tissue sarcoma. Journal of Clinical Oncology. 37: 22-22. DOI: 10.1200/jco.2019.37.8_suppl.22 |
0.01 |
|
| 2019 |
Chua-Alcala VS, Kim K, Assudani N, Al-Shihabi A, Quon D, Wong S, Chawla SP, Gordon EM. Initial results of a phase III investigation of safety/efficacy of nivolumab and ABI-009 (nab-sirolimus) in advanced undifferentiated pleomorphic sarcoma (UPS), liposarcoma (LPS), chondrosarcoma (CS), osteosarcoma (OS), and Ewing sarcoma. Journal of Clinical Oncology. 37: 21-21. DOI: 10.1200/JCO.2019.37.8_SUPPL.21 |
0.01 |
|
| 2019 |
Chawla SP, Chua VS, Gordon EM, Moradkhani A, Kim K, Quon D, Wong S, Sumner R, Mac V, Huang R, Wang K, Kim J, Kim B, McGinn AN, Park CH, et al. Phase I study to evaluate the safety and efficacy of rivoceranib (apatinib) and nivolumab in patients with unresectable or metastatic cancer. Journal of Clinical Oncology. 37: 18-18. DOI: 10.1200/Jco.2019.37.8_Suppl.18 |
0.01 |
|
| 2019 |
Gordon EM, Chua-Alcala VS, Kim K, Baby R, Angel N, Quon D, Wong S, Chawla SP. A phase I/II investigation of nivolumab and ABI-009 (nab-sirolimus) in advanced undifferentiated pleomorphic sarcoma (UPS), liposarcoma (LPS), chondrosarcoma (CS), osteosarcoma (OS), and Ewing sarcoma: Preliminary efficacy and safety results. Journal of Clinical Oncology. 37: 11057-11057. DOI: 10.1200/JCO.2019.37.15_SUPPL.11057 |
0.01 |
|
| 2019 |
Gordon EM, Chua-Alcala VS, Kim K, Liu S, Angel N, Baby R, Brigham D, Tseng WW, Pollack S, Jones RL, Federman N, Srikureja AM, Jalas J, Chawla SP. SAINT: Results of a phase 1/2 study of safety/efficacy using safe amounts of ipilimumab, nivolumab, and trabectedin as first-line treatment of advanced soft tissue sarcoma. Journal of Clinical Oncology. 37: 11016-11016. DOI: 10.1200/JCO.2019.37.15_SUPPL.11016 |
0.01 |
|
| 2019 |
Wagner AJ, Ravi V, Ganjoo KN, Tine BAV, Riedel RF, Chugh R, Cranmer LD, Gordon EM, Hornick JL, Kwiatkowski DJ, Du H, Grigorian B, Schmid AN, Hou S, Harris K, et al. ABI-009 (nab-sirolimus) in advanced malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial. Journal of Clinical Oncology. 37: 11005-11005. DOI: 10.1200/Jco.2019.37.15_Suppl.11005 |
0.01 |
|
| 2019 |
Gordon EM, Szeto C, Ravicz JR, Reddy S, Morse M, Chawla S, Hall F. Abstract 2556: Enhanced expression of human cyclin G1 (CCNG1) gene in metastatic cancer, a novel biomarker in development for CCNG1 inhibitor therapy Cancer Research. 79: 2556-2556. DOI: 10.1158/1538-7445.Am2019-2556 |
0.01 |
|
| 2018 |
Al-Shihabi A, Chawla SP, Hall FL, Gordon EM. Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy. Molecular Therapy - Oncolytics. 11: 122-126. PMID 30581985 DOI: 10.1016/J.Omto.2018.11.002 |
0.01 |
|
| 2018 |
Gordon EM, Ravicz JR, Liu S, Chawla SP, Hall FL. Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists. Molecular and Clinical Oncology. 9: 115-134. PMID 30101008 DOI: 10.3892/Mco.2018.1657 |
0.01 |
|
| 2018 |
Gordon EM, Chua-Alcala VS, Kim K, Tseng WW, Quon DM, Chawla SP. Phase 1/2 study of safety/efficacy using trabectedin, ipilimumab, and nivolumab as first-line treatment of advanced soft tissue sarcoma (STS). Journal of Clinical Oncology. 36: TPS46-TPS46. DOI: 10.1200/JCO.2018.36.5_SUPPL.TPS46 |
0.01 |
|
| 2018 |
Gordon EM, Chua-Alcala VS, Kim K, Quon DM, Chawla SP. A phase 1b investigation of safety/efficacy of nivolumab and ABI-009 (nab-rapamycin) in advanced undifferentiated pleomorphic sarcoma (UPS), liposarcoma (LPS), chondrosarcoma (CS), osteosarcoma (OS) and Ewing sarcoma. Journal of Clinical Oncology. 36: TPS45-TPS45. DOI: 10.1200/JCO.2018.36.5_suppl.TPS45 |
0.01 |
|
| 2018 |
Gordon EM, Sankhala KK, Stumpf N, Ravicz J, Arasheben S, Leong B, Kang G, Kim S, Tseng WW, Chawla SP. Cancer immunotherapy using trabectedin and nivolumab in advanced soft tissue sarcoma: A retrospective analysis. Journal of Clinical Oncology. 36: 40-40. DOI: 10.1200/JCO.2018.36.5_SUPPL.40 |
0.01 |
|
| 2018 |
Gordon EM, Li BM, Liu S, Chawla SP, Liu SM, Liu SM. RELAX: An immersion virtual reality relaxation intervention for quality of life improvement in cancer patients. Journal of Clinical Oncology. 36: 152-152. DOI: 10.1200/JCO.2018.36.34_SUPPL.152 |
0.01 |
|
| 2018 |
Wagner AJ, Riedel RF, Van Tine BA, Chugh R, Ganjoo KN, Cranmer LD, Pollack S, Sankhala KK, Gordon EM, Ravi V, Hornick JL, Kwiatkowski DJ, Grigorian B, Desai N, Dickson MA. Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa). Journal of Clinical Oncology. 36: TPS11589-TPS11589. DOI: 10.1200/JCO.2018.36.15_SUPPL.TPS11589 |
0.01 |
|
| 2018 |
Ravicz J, Liu S, Andrali SS, Reddy SK, Sellappan S, Leong B, Chawla SP, Hall FL, Gordon EM. Differential expression of human cyclin G1 (CCNG1) in cancer: A novel biomarker in development for CCNG1 inhibitor therapy. Journal of Clinical Oncology. 36: e24315-e24315. DOI: 10.1200/Jco.2018.36.15_Suppl.E24315 |
0.01 |
|
| 2018 |
Chawla SP, Sankhala KK, Ravicz J, Kang G, Liu S, Stumpf N, Leong B, Kim S, Arasheben S, Tseng WW, Gordon EM. Clinical experience with combination chemo-/immunotherapy using trabectedin and nivolumab for advanced soft tissue sarcoma. Journal of Clinical Oncology. 36: e23568-e23568. DOI: 10.1200/JCO.2018.36.15_SUPPL.E23568 |
0.01 |
|
| 2018 |
Andrali SS, Gordon EM, Reddy SK, Sellappan S, Chang J, Sachdev E, Chawla SP. Genomic and proteomic analysis of patient tumors for molecular target selection. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E23567 |
0.01 |
|
| 2017 |
Kim S, Federman N, Gordon EM, Hall FL, Chawla SP. Rexin-G(®), a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report. Molecular and Clinical Oncology. 6: 861-865. PMID 28588778 DOI: 10.3892/Mco.2017.1231 |
0.01 |
|
| 2017 |
Eilber FC, Sankhala KK, Chawla SP, Chua-Alcala VS, Gordon EM, Quon D, Kim K, Chawla S, Wu N, Wieland S, Levitt DJ. Administration of aldoxorubicin and 14 days continuous infusion of ifosfamide/mesna in metastatic or locally advanced sarcomas. Journal of Clinical Oncology. 35: 11051-11051. DOI: 10.1200/JCO.2017.35.15_SUPPL.11051 |
0.01 |
|
| 2017 |
Ženka J, Caisová V, Uher O, Nedbalová P, Kvardová K, Masáková K, Krejčová G, Paďouková L, Jochmanová I, Wolf KI, Chmelař J, Kopecký J, Loumagne L, Mestadier J, D’agostino S, ... ... Gordon EM, et al. Abstracts from the 4th ImmunoTherapy of Cancer Conference Journal For Immunotherapy of Cancer. 5. DOI: 10.1186/S40425-017-0219-4 |
0.01 |
|
| 2016 |
Gordon E, Rohrer JD, Fox NC. Advances in neuroimaging in frontotemporal dementia. Journal of Neurochemistry. 138: 193-210. PMID 27502125 DOI: 10.1111/Jnc.13656 |
0.01 |
|
| 2016 |
Thiessen C, Kulkarni S, Reese PP, Gordon EJ. A Call for Research on Individuals Who Opt Out of Living Kidney Donation: Challenges and Opportunities. Transplantation. PMID 27495760 DOI: 10.1097/TP.0000000000001408 |
0.01 |
|
| 2016 |
Gordon EJ, Sohn MW, Chang CH, McNatt G, Vera K, Beauvais N, Warren E, Mannon RB, Ison MG. Effect of a Mobile Web App on Kidney Transplant Candidates' Knowledge About Increased Risk Donor Kidneys: A Randomized Controlled Trial. Transplantation. PMID 27463536 DOI: 10.1097/TP.0000000000001273 |
0.01 |
|
| 2016 |
Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nature Reviews. Molecular Cell Biology. PMID 27461391 DOI: 10.1038/nrm.2016.87 |
0.01 |
|
| 2016 |
Gordon EJ, Fukuhara D, Weström S, Padhan N, Sjöström EO, van Meeteren L, He L, Orsenigo F, Dejana E, Bentley K, Spurkland A, Claesson-Welsh L. The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation. Science Signaling. 9: ra72. PMID 27436360 DOI: 10.1126/scisignal.aad9256 |
0.01 |
|
| 2016 |
Gordon ED, Simpson LJ, Rios CL, Ringel L, Lachowicz-Scroggins ME, Peters MC, Wesolowska-Andersen A, Gonzalez JR, MacLeod HJ, Christian LS, Yuan S, Barry L, Woodruff PG, Ansel KM, Nocka K, et al. Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27432971 DOI: 10.1073/Pnas.1601914113 |
0.01 |
|
| 2016 |
Frontera JA, Provencio JJ, Sehba FA, McIntyre TM, Nowacki AS, Gordon E, Weimer JM, Aledort L. The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid Hemorrhage. Neurocritical Care. PMID 27430874 DOI: 10.1007/S12028-016-0292-4 |
0.01 |
|
| 2016 |
Kay C, Collins JA, Miedzybrodzka Z, Madore SJ, Gordon ES, Gerry N, Davidson M, Slama RA, Hayden MR. Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology. PMID 27335115 DOI: 10.1212/Wnl.0000000000002858 |
0.01 |
|
| 2016 |
Yao X, Gordon EM, Barochia AV, Remaley AT, Levine SJ. The A's have it: Developing Apolipoprotein A-I Mimetic Peptides into a Novel Treatment for Asthma. Chest. PMID 27327118 DOI: 10.1016/j.chest.2016.05.035 |
0.01 |
|
| 2016 |
Sarkiss CA, Papin JA, Yao A, Lee J, Sefcik RK, Oermann EK, Gordon EL, Post KD, Bederson JB, Shrivastava RK. Day of Surgery Impacts Outcome: Rehabilitation Utilization on Hospital Length of Stay in Patients Undergoing Elective Meningioma Resection. World Neurosurgery. PMID 27297242 DOI: 10.1016/j.wneu.2016.06.003 |
0.01 |
|
| 2016 |
Gordon EJ, Mullee J, Skaro A, Baker T. Live liver donors' information needs: A qualitative study of practical implications for informed consent. Surgery. PMID 27269968 DOI: 10.1016/j.surg.2016.04.022 |
0.01 |
|
| 2016 |
Gordon EM, Sankhala KK, Chawla N, Chawla SP. Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives. Advances in Therapy. PMID 27234989 DOI: 10.1007/s12325-016-0344-3 |
0.01 |
|
| 2016 |
Weimer JM, Gordon E, Frontera JA. Predictors of Functional Outcome After Subdural Hematoma: A Prospective Study. Neurocritical Care. PMID 27230968 DOI: 10.1007/s12028-016-0279-1 |
0.01 |
|
| 2016 |
Fernandez KC, Gordon EA, Rodebaugh TL, Heimberg RG. Exploring linguistic correlates of social anxiety in romantic stories. Cognitive Behaviour Therapy. 1-16. PMID 27216791 DOI: 10.1080/16506073.2016.1184711 |
0.01 |
|
| 2016 |
Sweerus K, Lachowicz-Scroggins M, Gordon E, LaFemina M, Huang X, Parikh M, Kanegai C, Fahy JV, Frank JA. Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma. The Journal of Allergy and Clinical Immunology. PMID 27215490 DOI: 10.1016/j.jaci.2016.02.035 |
0.01 |
|
| 2016 |
Grieve SM, Korgaonkar MS, Gordon E, Williams LM, Rush AJ. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. The Journal of Clinical Psychiatry. 77: e436-e443. PMID 27137427 DOI: 10.4088/Jcp.14M09577 |
0.01 |
|
| 2016 |
Gordon EJ, Feinglass J, Carney P, Vera K, Olivero M, Black A, O'Connor KG, Baumgart JM, Caicedo JC. A Website Intervention to Increase Knowledge About Living Kidney Donation and Transplantation Among Hispanic/Latino Dialysis Patients. Progress in Transplantation (Aliso Viejo, Calif.). 26: 82-91. PMID 27136254 DOI: 10.1177/1526924816632124 |
0.01 |
|
| 2016 |
Gordon ED, Locksley RM, Fahy JV. Cross-Talk between Epithelial Cells and Type 2 Immune Signaling. The Role of IL-25. American Journal of Respiratory and Critical Care Medicine. 193: 935-6. PMID 27128698 DOI: 10.1164/Rccm.201512-2534Ed |
0.01 |
|
| 2016 |
Shahabi P, Scheinfeldt LB, Lynch DE, Schmidlen TJ, Perreault S, Keller MA, Kasper R, Wawak L, Jarvis JP, Gerry NP, Gordon ES, Christman MF, Dubé MP, Gharani N. An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance. Thrombosis and Haemostasis. 116. PMID 27121899 DOI: 10.1160/Th15-12-0955 |
0.01 |
|
| 2016 |
Mills D, Gomberawalla A, Gordon EJ, Tondre J, Nejad M, Nguyen T, Pogoda JM, Rao J, Chatterton R, Henning S, Love SM. Examination of Duct Physiology in the Human Mammary Gland. Plos One. 11: e0150653. PMID 27073976 DOI: 10.1371/Journal.Pone.0150653 |
0.01 |
|
| 2016 |
Yao X, Gordon EM, Figueroa DM, Barochia AV, Levine SJ. The Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease. American Journal of Respiratory Cell and Molecular Biology. PMID 27073971 DOI: 10.1165/rcmb.2016-0060TR |
0.01 |
|
| 2016 |
Li X, Padhan N, Sjöström EO, Roche FP, Testini C, Honkura N, Sáinz-Jaspeado M, Gordon E, Bentley K, Philippides A, Tolmachev V, Dejana E, Stan RV, Vestweber D, Ballmer-Hofer K, et al. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread. Nature Communications. 7: 11017. PMID 27005951 DOI: 10.1038/Ncomms11017 |
0.01 |
|
| 2016 |
Gordon EE, Xiang H, Köhler J, Whangbo MH. Spin orientations of the spin-half Ir(4+) ions in Sr3NiIrO6, Sr2IrO4, and Na2IrO3: Density functional, perturbation theory, and Madelung potential analyses. The Journal of Chemical Physics. 144: 114706. PMID 27004892 DOI: 10.1063/1.4943889 |
0.01 |
|
| 2016 |
Foy SP, Mandl SJ, Dela Cruz T, Cote JJ, Gordon EJ, Trent E, Delcayre A, Breitmeyer J, Franzusoff A, Rountree RB. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells. Cancer Immunology, Immunotherapy : Cii. PMID 26961085 DOI: 10.1007/S00262-016-1816-7 |
0.01 |
|
| 2016 |
Van Kiersbilck C, Gordon E, Morris D. Ten things that nurses should know about ECMO. Intensive Care Medicine. PMID 26957080 DOI: 10.1007/s00134-016-4293-8 |
0.01 |
|
| 2016 |
Zhang J, Gordon ER, Forthman M, Hwang WS, Walden K, Swanson DR, Johnson KP, Meier R, Weirauch C. Evolution of the assassin's arms: insights from a phylogeny of combined transcriptomic and ribosomal DNA data (Heteroptera: Reduvioidea). Scientific Reports. 6: 22177. PMID 26916580 DOI: 10.1038/Srep22177 |
0.01 |
|
| 2016 |
Foy SP, Sennino B, Dela Cruz T, Cote JJ, Gordon EJ, Kemp F, Xavier V, Franzusoff A, Rountree RB, Mandl SJ. Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice. Plos One. 11: e0150084. PMID 26910562 DOI: 10.1371/Journal.Pone.0150084 |
0.01 |
|
| 2016 |
Robinson JK, Friedewald JJ, Desai A, Gordon EJ. A Randomized Controlled Trial of a Mobile Medical App for Kidney Transplant Recipients: Effect on Use of Sun Protection. Transplantation Direct. 2. PMID 26900599 DOI: 10.1097/TXD.0000000000000561 |
0.01 |
|
| 2016 |
Singhvi A, Welch AN, Levitsky J, Singhvi D, Gordon EJ. Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases. Ama Journal of Ethics. 18: 163-73. PMID 26894813 DOI: 10.1001/journalofethics.2016.18.2.sect1-1602 |
0.01 |
|
| 2016 |
Gordon EE, Xu K, Xiang H, Bussmann-Holder A, Kremer RK, Simon A, Köhler J, Whangbo MH. Structure and Composition of the 200 K-Superconducting Phase of H2 S at Ultrahigh Pressure: The Perovskite (SH(-) )(H3 S(+) ). Angewandte Chemie (International Ed. in English). PMID 26855072 DOI: 10.1002/Anie.201511347 |
0.01 |
|
| 2016 |
Ramakrishna H, Gutsche JT, Evans AS, Patel PA, Weiner M, Morozowich ST, Gordon EK, Riha H, Shah R, Ghadimi K, Zhou E, Fernadno R, Yoon J, Wakim M, Atchley L, et al. The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2015. Journal of Cardiothoracic and Vascular Anesthesia. 30: 1-9. PMID 26847747 DOI: 10.1053/j.jvca.2015.09.012 |
0.01 |
|
| 2016 |
Volkmann RA, Fanger CM, Anderson DR, Sirivolu VR, Paschetto K, Gordon E, Virginio C, Gleyzes M, Buisson B, Steidl E, Mierau SB, Fagiolini M, Menniti FS. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. Plos One. 11: e0148129. PMID 26829109 DOI: 10.1371/Journal.Pone.0148129 |
0.01 |
|
| 2016 |
McDermott AF, Rose M, Norris T, Gordon E. A Novel Feed-Forward Modeling System Leads to Sustained Improvements in Attention and Academic Performance. Journal of Attention Disorders. PMID 26823382 DOI: 10.1177/1087054715623044 |
0.01 |
|
| 2016 |
Rabideau MM, Wong K, Gordon ES, Ryan L. Genetic Counselors in Startup Companies: Redefining the Genetic Counselor Role. Journal of Genetic Counseling. PMID 26801784 DOI: 10.1007/s10897-015-9923-8 |
0.01 |
|
| 2016 |
Sen S, Losey BP, Gordon EE, Argyropoulos DS, Martin JD. Ionic Liquid Character of Zinc Chloride Hydrates Define Solvent Characteristics that Afford Solubility of Cellulose. The Journal of Physical Chemistry. B. PMID 26800761 DOI: 10.1021/Acs.Jpcb.5B11400 |
0.01 |
|
| 2016 |
Gordon EJ, Gill JS. US Transplant Policy Should Strengthen Bridges, Not Build Walls. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 16: 1645-6. PMID 26752683 DOI: 10.1111/ajt.13713 |
0.01 |
|
| 2016 |
Olbrich S, Tränkner A, Surova G, Gevirtz R, Gordon E, Hegerl U, Arns M. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study. Journal of Psychiatric Research. 73: 108-15. PMID 26714202 DOI: 10.1016/J.Jpsychires.2015.12.001 |
0.01 |
|
| 2016 |
Rothenberg DA, Gordon EA, White FM, Lourido S. Identification of Direct Kinase Substrates Using Analogue-Sensitive Alleles. Methods in Molecular Biology (Clifton, N.J.). 1355: 71-84. PMID 26584919 DOI: 10.1007/978-1-4939-3049-4_5 |
0.01 |
|
| 2016 |
Fleetwood F, Güler R, Gordon E, Ståhl S, Claesson-Welsh L, Löfblom J. Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling. Cellular and Molecular Life Sciences : Cmls. 73: 1671-83. PMID 26552422 DOI: 10.1007/s00018-015-2088-7 |
0.01 |
|
| 2016 |
Gordon ER, Weirauch C. Efficient capture of natural history data reveals prey conservatism of cryptic termite predators. Molecular Phylogenetics and Evolution. 94: 65-73. PMID 26314664 DOI: 10.1016/J.Ympev.2015.08.015 |
0.01 |
|
| 2016 |
Robinson JK, Friedewald J, Gordon EJ. Perceptions of Risk of Developing Skin Cancer for Diverse Audiences: Enhancing Relevance of Sun Protection to Reduce the Risk. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 31: 153-7. PMID 26209181 DOI: 10.1007/s13187-015-0885-1 |
0.01 |
|
| 2016 |
Chawla SP, Sankhala KK, Chawla S, Chua VS, Gordon EM, Chawla NS, Sung K, Wieland S, Levitt DJ. A phase 1/2 study of continuous infusion ifosfamide/mesna + aldoxorubicin in sarcoma patients. Journal of Clinical Oncology. 34: e22547-e22547. DOI: 10.1200/JCO.2016.34.15_SUPPL.E22547 |
0.01 |
|
| 2016 |
Syed I, Sudan M, Tseng W, Parthasarathy P, Mendanha WE, Chawla NS, Nanda R, Daneshrad J, Leong B, Aryanfar B, Arasheben S, Kim K, Gordon EM, Sankhala KK, Chawla SP. Trabectedin for advanced soft-tissue sarcoma: A single-center experience of over 10 years. Journal of Clinical Oncology. 34: 11052-11052. DOI: 10.1200/JCO.2016.34.15_SUPPL.11052 |
0.01 |
|
| 2016 |
Hall FL, Chawla SP, Chawla NS, Gordon EM. Abstract 2203: Targeting monoclonal antibodies to the tumor microenvironment for cancer immunotherapy Cancer Research. 76: 2203-2203. DOI: 10.1158/1538-7445.Am2016-2203 |
0.01 |
|
| 2016 |
Chawla S, Sankhala K, Chawla S, Chua V, Gordon E, Chawla N, Sung K, Quon D, Kim K, Fernandez L, Leong B, Wieland S, Levitt D. First line therapy with aldoxorubicin and 14 days continuous infusion of ifosfamide/mesna in metastatic or locally advanced sarcomas: a phase I-II study Annals of Oncology. 27: vi487. DOI: 10.1093/annonc/mdw388.13 |
0.01 |
|
| 2015 |
Gordon EJ, Lee J, Kang R, Ladner DP, Skaro AI, Holl JL, French DD, Abecassis MM, Caicedo JC. Hispanic/Latino Disparities in Living Donor Kidney Transplantation: Role of a Culturally Competent Transplant Program. Transplantation Direct. 1: e29. PMID 27500229 DOI: 10.1097/Txd.0000000000000540 |
0.01 |
|
| 2015 |
Barthélemy EJ, Melis M, Gordon E, Ullman JS, Germano I. Decompressive Craniectomy for Severe Traumatic Brain Injury: A Systematic Review. World Neurosurgery. PMID 26732949 DOI: 10.1016/j.wneu.2015.12.044 |
0.01 |
|
| 2015 |
Sarkiss CA, Philemond S, Lee J, Sobotka S, Holloway TD, Moore M, Costa AB, Gordon EL, Bederson JB. Neurosurgical Skills Assessment: Measuring Technical Proficiency in Neurosurgery Residents through Intraoperative Video Evaluations. World Neurosurgery. PMID 26724633 DOI: 10.1016/j.wneu.2015.12.052 |
0.01 |
|
| 2015 |
Arns M, Gordon E, Boutros NN. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study. Clinical Eeg and Neuroscience. PMID 26674366 DOI: 10.1177/1550059415621435 |
0.01 |
|
| 2015 |
Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B. Tranexamic acid decreases blood loss after total shoulder arthroplasty. Journal of Shoulder and Elbow Surgery / American Shoulder and Elbow Surgeons ... [Et Al.]. PMID 26652697 DOI: 10.1016/j.jse.2015.09.014 |
0.01 |
|
| 2015 |
Poldrack RA, Laumann TO, Koyejo O, Gregory B, Hover A, Chen MY, Gorgolewski KJ, Luci J, Joo SJ, Boyd RL, Hunicke-Smith S, Simpson ZB, Caven T, Sochat V, Shine JM, Gordon E, et al. Long-term neural and physiological phenotyping of a single human. Nature Communications. 6: 8885. PMID 26648521 DOI: 10.1038/Ncomms9885 |
0.01 |
|
| 2015 |
Serur D, Gordon EJ. Kidney donors at risk: how to inform the donor. Progress in Transplantation (Aliso Viejo, Calif.). 25: 284-6. PMID 26645918 DOI: 10.7182/pit2015682 |
0.01 |
|
| 2015 |
Whangbo MH, Gordon EE, Xiang H, Koo HJ, Lee C. Prediction of Spin Orientations in Terms of HOMO-LUMO Interactions Using Spin-Orbit Coupling as Perturbation. Accounts of Chemical Research. PMID 26616364 DOI: 10.1021/acs.accounts.5b00408 |
0.01 |
|
| 2015 |
Lederer S, Fischer MJ, Gordon HS, Wadhwa A, Popli S, Gordon EJ. Barriers to effective communication between veterans with chronic kidney disease and their healthcare providers. Clinical Kidney Journal. 8: 766-71. PMID 26613037 DOI: 10.1093/ckj/sfv079 |
0.01 |
|
| 2015 |
Bocchetta M, Gordon E, Marshall CR, Slattery CF, Cardoso MJ, Cash DM, Espak M, Modat M, Ourselin S, Frisoni GB, Schott JM, Warren JD, Rohrer JD. The habenula: an under-recognised area of importance in frontotemporal dementia? Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26567261 DOI: 10.1136/jnnp-2015-312067 |
0.01 |
|
| 2015 |
Gordon E. State intervention in pregnancy: Should the law respond thus to the problem of Foetal Alcohol Spectrum Disorder? Journal of Law and Medicine. 23: 156-88. PMID 26554205 |
0.01 |
|
| 2015 |
Zwaans W, Verhagen T, Roumen R, Scheltinga M, Dieleman J, Vad M, Frost P, Rosenberg J, Svendsen SW, Tabbara M, Carandina S, Bossi M, Polliand C, Barrat C, Soler M, ... ... Gordon EM, et al. Topic: Inguinal Hernia - Post op chronic pain: incidence, evaluation, legal consequences, therapy, follow up. Hernia : the Journal of Hernias and Abdominal Wall Surgery. 19: S267-S274. PMID 26518822 DOI: 10.1007/BF03355370 |
0.01 |
|
| 2015 |
Yerys BE, Gordon EM, Abrams DN, Satterthwaite TD, Weinblatt R, Jankowski KF, Strang J, Kenworthy L, Gaillard WD, Vaidya CJ. Default mode network segregation and social deficits in autism spectrum disorder: Evidence from non-medicated children. Neuroimage. Clinical. 9: 223-32. PMID 26484047 DOI: 10.1016/J.Nicl.2015.07.018 |
0.01 |
|
| 2015 |
Gordon EM, Laumann TO, Adeyemo B, Petersen SE. Individual Variability of the System-Level Organization of the Human Brain. Cerebral Cortex (New York, N.Y. : 1991). PMID 26464473 DOI: 10.1093/Cercor/Bhv239 |
0.01 |
|
| 2015 |
Gordon EJ, Feinglass J, Carney P, Vera K, Olivero M, Black A, OʼConnor K, MacLean J, Nichols S, Sageshima J, Preczewski L, Caicedo JC. A Culturally Targeted Website for Hispanics/Latinos About Living Kidney Donation and Transplantation: A Randomized Controlled Trial of Increased Knowledge. Transplantation. PMID 26444846 DOI: 10.1097/TP.0000000000000932 |
0.01 |
|
| 2015 |
Clark CN, Nicholas JM, Gordon E, Golden HL, Cohen MH, Woodward FJ, Macpherson K, Slattery CF, Mummery CJ, Schott JM, Rohrer JD, Warren JD. Altered Sense of Humor in Dementia. Journal of Alzheimer's Disease : Jad. PMID 26444779 DOI: 10.3233/JAD-150413 |
0.01 |
|
| 2015 |
Lucas AD, Nagaraja S, Gordon EA, Hitchins VM. Evaluating Device Design and Cleanability of Orthopedic Device Models Contaminated with a Clinically Relevant Bone Test Soil. Biomedical Instrumentation & Technology / Association For the Advancement of Medical Instrumentation. 49: 354-62. PMID 26443915 DOI: 10.2345/0899-8205-49.5.354 |
0.01 |
|
| 2015 |
Gordon EB, Hart GT, Tran TM, Waisberg M, Akkaya M, Kim AS, Hamilton SE, Pena M, Yazew T, Qi CF, Lee CF, Lo YC, Miller LH, Powell JD, Pierce SK. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America. PMID 26438846 DOI: 10.1073/Pnas.1516544112 |
0.01 |
|
| 2015 |
Carter R, Chatterjee S, Gordon E, Share K, Erwin WR, Cohn AP, Bardhan R, Pint CL. Corrosion resistant three-dimensional nanotextured silicon for water photo-oxidation. Nanoscale. PMID 26400265 DOI: 10.1039/C5Nr03897A |
0.01 |
|
| 2015 |
Dai C, Yao X, Gordon EM, Barochia A, Cuento RA, Kaler M, Meyer KS, Keeran KJ, Nugent GZ, Jeffries KR, Qu X, Yu ZX, Aponte A, Gucek M, Dagur PK, et al. A CCL24-dependent pathway augments eosinophilic airway inflammation in house dust mite-challenged Cd163(-/-) mice. Mucosal Immunology. PMID 26376364 DOI: 10.1038/mi.2015.94 |
0.01 |
|
| 2015 |
Jamieson NJ, Hanson CS, Josephson MA, Gordon EJ, Craig JC, Halleck F, Budde K, Tong A. Motivations, Challenges, and Attitudes to Self-management in Kidney Transplant Recipients: A Systematic Review of Qualitative Studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 26372087 DOI: 10.1053/j.ajkd.2015.07.030 |
0.01 |
|
| 2015 |
Asare EA, Liu L, Hess KR, Gordon EJ, Paruch JL, Palis B, Dahlke AR, McCabe R, Cohen ME, Winchester DP, Bilimoria KY. Development of a model to predict breast cancer survival using data from the National Cancer Data Base. Surgery. PMID 26365950 DOI: 10.1016/j.surg.2015.08.006 |
0.01 |
|
| 2015 |
Bocchetta M, Gordon E, Manning E, Barnes J, Cash DM, Espak M, Thomas DL, Modat M, Rossor MN, Warren JD, Ourselin S, Frisoni GB, Rohrer JD. Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia. Journal of Neurology. PMID 26338813 DOI: 10.1007/S00415-015-7885-2 |
0.01 |
|
| 2015 |
Scheinfeldt LB, Gharani N, Kasper RS, Schmidlen TJ, Gordon ES, Jarvis JP, Delaney S, Kronenthal CJ, Gerry NP, Christman MF. Using the Coriell Personalized Medicine Collaborative Data to conduct a genome-wide association study of sleep duration. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 26333835 DOI: 10.1002/Ajmg.B.32362 |
0.01 |
|
| 2015 |
Gordon EA, Corbitt C. Investigation of pre-pubertal sex differences in wheel running and social behavior in three mouse strains. Journal of Ethology. 33: 177-187. PMID 26316671 DOI: 10.1007/s10164-015-0429-5 |
0.01 |
|
| 2015 |
Grisaru-Granovsky S, Gordon ES, Haklai Z, Schimmel MS, Drukker L, Samueloff A, Keinan-Boker L. Delivery of a very low birth weight infant and increased maternal risk of cancer and death: a population study with 16 years of follow-up. Cancer Causes & Control : Ccc. 26: 1593-601. PMID 26316180 DOI: 10.1007/s10552-015-0653-x |
0.01 |
|
| 2015 |
Schmidlen TJ, Scheinfeldt L, Zhaoyang R, Kasper R, Sweet K, Gordon ES, Keller M, Stack C, Gharani N, Daly MB, Jarvis J, Christman MF. Genetic Knowledge Among Participants in the Coriell Personalized Medicine Collaborative. Journal of Genetic Counseling. PMID 26306685 DOI: 10.1007/S10897-015-9883-Z |
0.01 |
|
| 2015 |
Cohen LJ, Kang HS, Chu J, Huang YH, Gordon EA, Reddy BV, Ternei MA, Craig JW, Brady SF. Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist. Proceedings of the National Academy of Sciences of the United States of America. 112: E4825-34. PMID 26283367 DOI: 10.1073/Pnas.1508737112 |
0.01 |
|
| 2015 |
Dinteren RV, Arns M, Kenemans L, Jongsma ML, Kessels RP, Fitzgerald P, Fallahpour K, Debattista C, Gordon E, Williams LM. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26282359 DOI: 10.1016/J.Euroneuro.2015.07.022 |
0.01 |
|
| 2015 |
Patel SK, Gordon EJ, Wong CA, Grobman WA, Goucher H, Toledo P. Readability, Content, and Quality Assessment of Web-Based Patient Education Materials Addressing Neuraxial Labor Analgesia. Anesthesia and Analgesia. 121: 1295-300. PMID 26252170 DOI: 10.1213/ANE.0000000000000888 |
0.01 |
|
| 2015 |
Laumann TO, Gordon EM, Adeyemo B, Snyder AZ, Joo SJ, Chen MY, Gilmore AW, McDermott KB, Nelson SM, Dosenbach NU, Schlaggar BL, Mumford JA, Poldrack RA, Petersen SE. Functional System and Areal Organization of a Highly Sampled Individual Human Brain. Neuron. PMID 26212711 DOI: 10.1016/J.Neuron.2015.06.037 |
0.01 |
|
| 2015 |
McElroy LM, Macapagal KR, Collins KM, Abecassis MM, Holl JL, Ladner DP, Gordon EJ. Clinician perceptions of operating room to intensive care unit handoffs and implications for patient safety: a qualitative study. American Journal of Surgery. 210: 629-35. PMID 26198333 DOI: 10.1016/J.Amjsurg.2015.05.008 |
0.01 |
|
| 2015 |
Arns M, Bruder G, Hegerl U, Spooner C, Palmer DM, Etkin A, Fallahpour K, Gatt JM, Hirshberg L, Gordon E. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 26189209 DOI: 10.1016/J.Clinph.2015.05.032 |
0.01 |
|
| 2015 |
Korgaonkar MS, Rekshan W, Gordon E, Rush AJ, Williams LM, Blasey C, Grieve SM. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder. Ebiomedicine. 2: 37-45. PMID 26137532 DOI: 10.1016/J.Ebiom.2014.12.002 |
0.01 |
|
| 2015 |
Aspalter IM, Gordon E, Dubrac A, Ragab A, Narloch J, Vizán P, Geudens I, Collins RT, Franco CA, Abrahams CL, Thurston G, Fruttiger M, Rosewell I, Eichmann A, Gerhardt H. Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. Nature Communications. 6: 7264. PMID 26081042 DOI: 10.1038/ncomms8264 |
0.01 |
|
| 2015 |
Titler M, Maquivar MG, Bas S, Rajala-Schultz PJ, Gordon E, McCullough K, Federico P, Schuenemann GM. Prediction of parturition in Holstein dairy cattle using electronic data loggers. Journal of Dairy Science. 98: 5304-12. PMID 26074226 DOI: 10.3168/Jds.2014-9223 |
0.01 |
|
| 2015 |
Gordon EE, Reinking BE, Hu S, Yao J, Kua KL, Younes AK, Wang C, Segar JL, Norris AW. Maternal Hyperglycemia Directly and Rapidly Induces Cardiac Septal Overgrowth in Fetal Rats. Journal of Diabetes Research. 2015: 479565. PMID 26064981 DOI: 10.1155/2015/479565 |
0.01 |
|
| 2015 |
Gordon EB, Hart GT, Tran TM, Waisberg M, Akkaya M, Skinner J, Zinöcker S, Pena M, Yazew T, Qi CF, Miller LH, Pierce SK. Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria. Mbio. 6. PMID 26037126 DOI: 10.1128/Mbio.00725-15 |
0.01 |
|
| 2015 |
Gordon EJ, Rodde J, Skaro A, Baker T. Informed consent for live liver donors: A qualitative, prospective study. Journal of Hepatology. 63: 838-47. PMID 26003265 DOI: 10.1016/j.jhep.2015.05.003 |
0.01 |
|
| 2015 |
D'Alessandro LC, Al Turki S, Manickaraj AK, Manase D, Mulder BJ, Bergin L, Rosenberg HC, Mondal T, Gordon E, Lougheed J, Smythe J, Devriendt K, Bhattacharya S, Watkins H, Bentham J, et al. Exome sequencing identifies rare variants in multiple genes in atrioventricular septal defect. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25996639 DOI: 10.1038/Gim.2015.60 |
0.01 |
|
| 2015 |
Gordon EJ, Mullee J, Butt Z, Kang J, Baker T. Optimizing informed consent in live liver donors: Evaluation of a comprehension assessment tool. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 25990592 DOI: 10.1002/Lt.24175 |
0.01 |
|
| 2015 |
Read CM, Gordon EE, Smith MD, Yeon J, Morrison G, Whangbo MH, Zur Loye HC. Synthesis of the Layered Quaternary Uranium-Containing Oxide Cs2Mn3U6O22 and Characterization of its Magnetic Properties. Inorganic Chemistry. 54: 5495-503. PMID 25954859 DOI: 10.1021/Acs.Inorgchem.5B00552 |
0.01 |
|
| 2015 |
Arns M, Etkin A, Hegerl U, Williams LM, DeBattista C, Palmer DM, Fitzgerald PB, Harris A, deBeuss R, Gordon E. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: Implications for treatment outcome? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 25936227 DOI: 10.1016/J.Euroneuro.2015.03.007 |
0.01 |
|
| 2015 |
Tan JC, Gordon EJ, Dew MA, LaPointe Rudow D, Steiner RW, Woodle ES, Hays R, Rodrigue JR, Segev DL. Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation-Recommendations from a Consensus Conference. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 25908792 DOI: 10.2215/Cjn.01030115 |
0.01 |
|
| 2015 |
Gordon E. The overriding objective. British Dental Journal. 218: 439-40. PMID 25908341 DOI: 10.1038/sj.bdj.2015.304 |
0.01 |
|
| 2015 |
Gordon EJ, Feinglass J, Carney P, Ramirez D, Olivero M, O'Connor K, MacLean J, Brucker J, Caicedo JC. An interactive, bilingual, culturally targeted website about living kidney donation and transplantation for hispanics: development and formative evaluation. Jmir Research Protocols. 4: e42. PMID 25896143 DOI: 10.2196/resprot.3838 |
0.01 |
|
| 2015 |
Thiessen C, Gordon EJ, Reese PP, Kulkarni S. Development of a Donor-Centered Approach to Risk Assessment: Rebalancing Non-maleficence and Autonomy. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 25868787 DOI: 10.1111/ajt.13272 |
0.01 |
|
| 2015 |
Fisher JS, Butt Z, Friedewald J, Fry-Revere S, Hanneman J, Henderson ML, Ladin K, Mysel H, Preczewski L, Sherman LA, Thiessen C, Gordon EJ. Between Scylla and Charybdis: charting an ethical course for research into financial incentives for living kidney donation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1180-6. PMID 25833728 DOI: 10.1111/Ajt.13234 |
0.01 |
|
| 2015 |
Gordon E, Rush AJ, Palmer DM, Braund TA, Rekshan W. Toward an online cognitive and emotional battery to predict treatment remission in depression. Neuropsychiatric Disease and Treatment. 11: 517-31. PMID 25750532 DOI: 10.2147/Ndt.S75975 |
0.01 |
|
| 2015 |
Diseati L, Scheinfeldt LB, Kasper RS, Zhaoyang R, Gharani N, Schmidlen TJ, Gordon ES, Sessions CK, Delaney SK, Jarvis JP, Gerry N, Christman M. Common genetic risk for melanoma encourages preventive behavior change. Journal of Personalized Medicine. 5: 36-49. PMID 25695399 DOI: 10.3390/Jpm5010036 |
0.01 |
|
| 2015 |
Barochia AV, Kaler M, Cuento RA, Gordon EM, Weir NA, Sampson M, Fontana JR, MacDonald S, Moss J, Manganiello V, Remaley AT, Levine SJ. Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma. American Journal of Respiratory and Critical Care Medicine. 191: 990-1000. PMID 25692941 DOI: 10.1164/Rccm.201411-1990Oc |
0.01 |
|
| 2015 |
Devraj R, Borrego M, Vilay AM, Gordon EJ, Pailden J, Horowitz B. Relationship between Health Literacy and Kidney Function. Nephrology (Carlton, Vic.). 20: 360-7. PMID 25661456 DOI: 10.1111/Nep.12425 |
0.01 |
|
| 2015 |
LaPointe Rudow D, Hays R, Baliga P, Cohen DJ, Cooper M, Danovitch GM, Dew MA, Gordon EJ, Mandelbrot DA, McGuire S, Milton J, Moore DR, Morgievich M, Schold JD, Segev DL, et al. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 914-22. PMID 25648884 DOI: 10.1111/Ajt.13173 |
0.01 |
|
| 2015 |
De Maria Antolinos A, Pernot P, Brennich ME, Kieffer J, Bowler MW, Delageniere S, Ohlsson S, Malbet Monaco S, Ashton A, Franke D, Svergun D, McSweeney S, Gordon E, Round A. ISPyB for BioSAXS, the gateway to user autonomy in solution scattering experiments. Acta Crystallographica. Section D, Biological Crystallography. 71: 76-85. PMID 25615862 DOI: 10.1107/S1399004714019609 |
0.01 |
|
| 2015 |
Saveanu R, Etkin A, Duchemin AM, Goldstein-Piekarski A, Gyurak A, Debattista C, Schatzberg AF, Sood S, Day CV, Palmer DM, Rekshan WR, Gordon E, Rush AJ, Williams LM. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. Journal of Psychiatric Research. 61: 1-12. PMID 25586212 DOI: 10.1016/J.Jpsychires.2014.12.018 |
0.01 |
|
| 2015 |
Hellemans A, Perkel JM, Lockwood D, Gordon EJ. Spotlights on recent JACS publications. Journal of the American Chemical Society. 137: 1. PMID 25585585 DOI: 10.1021/jacs.5b00140 |
0.01 |
|
| 2015 |
Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Iung B, Freeman LJ, Gordon EP, Pieper PG, Hall R, Boersma E, Johnson MR. Is a planned caesarean section in women with cardiac disease beneficial? Heart (British Cardiac Society). 101: 530-6. PMID 25539946 DOI: 10.1136/heartjnl-2014-306497 |
0.01 |
|
| 2014 |
Gordon EE. A regional focus for solving the skills-jobs mismatch. Surgical Neurology International. 5: 176. PMID 25593760 DOI: 10.4103/2152-7806.146815 |
0.01 |
|
| 2011 |
Ignacio JG, Bruckner H, Manalo RE, San Juan FS, Baniqued L, Madamba A, Gordon EM, Hall FL. Tumor-targeted cancer vaccination (GeneVieve Protocol): A phase I/II study of intravenous Rexin-G and Reximmune-C for chemotherapy-resistant cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2589. PMID 28022264 DOI: 10.1200/Jco.2011.29.15_Suppl.2589 |
0.01 |
|
| 2010 |
Hall FL, Levy JP, Reed RA, Petchpud WN, Chua VS, Chawla SP, Gordon EM. Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery. Oncology Reports. 24: 829-33. PMID 20811660 DOI: 10.3892/Or.2010.829 |
0.01 |
|
| 2010 |
Gordon EM, Hall FL. Noteworthy clinical case studies in cancer gene therapy: tumor-targeted Rexin-G advances as an efficacious anti-cancer agent. International Journal of Oncology. 36: 1341-53. PMID 20428757 DOI: 10.3892/Ijo_00000619 |
0.01 |
|
| 2010 |
Gordon EM, Hall FL. Rexin-G, a targeted genetic medicine for cancer. Expert Opinion On Biological Therapy. 10: 819-32. PMID 20384524 DOI: 10.1517/14712598.2010.481666 |
0.01 |
|
| 2010 |
Chawla SP, Chua VS, Fernandez L, Quon D, Blackwelder WC, Gordon EM, Hall FL. Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 435-41. PMID 19826403 DOI: 10.1038/Mt.2009.228 |
0.01 |
|
| 2010 |
Bruckner H, Chawla SP, Chua CS, Quon DV, Fernandez L, Saralou A, Fisher M, Gordon EM, Hall FL. Phase I and II studies of intravenous Rexin-G as monotherapy for stage IVb gemcitabine-resistant pancreatic cancer. Journal of Clinical Oncology. 28: 4149-4149. DOI: 10.1200/Jco.2010.28.15_Suppl.4149 |
0.01 |
|
| 2010 |
Ignacio JG, Chawla SP, Manalo RE, Baniqued L, Juan FSS, Madamba A, Hall FL, Gordon EM. A phase I/II study of intravenous Rexin-G and Reximmune-C for cancer immunotherapy: The GeneVieve protocol. Journal of Clinical Oncology. 28: 2546-2546. DOI: 10.1200/Jco.2010.28.15_Suppl.2546 |
0.01 |
|
| 2010 |
Ganjoo KN, Chawla SP, Chua VS, Fernandez L, Quon DV, Saralou A, Hall FL, Gordon EM. Advanced phase I/II evaluation of tumor-targeted gene delivery: Intravenous retrovector encoding mutant anticyclin G1 as stand-alone therapy for chemotherapy-resistant bone and soft tissue sarcoma. Journal of Clinical Oncology. 28: 10010-10010. DOI: 10.1200/Jco.2010.28.15_Suppl.10010 |
0.01 |
|
| 2009 |
Chawla SP, Chua VS, Fernandez L, Quon D, Saralou A, Blackwelder WC, Hall FL, Gordon EM. Evaluation of the safety and efficacy of pathotropic nanoparticles bearing a dominant negative cyclin G1 construct for chemoresistant osteosarcoma and other sarcomas: Phase I, II, and III studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 10513. PMID 27963649 DOI: 10.1200/Jco.2009.27.15_Suppl.10513 |
0.01 |
|
| 2009 |
Gordon EM, Hall FL. The 'timely' development of Rexin-G: first targeted injectable gene vector (review). International Journal of Oncology. 35: 229-38. PMID 19578735 DOI: 10.3892/Ijo_00000332 |
0.01 |
|
| 2009 |
Chawla SP, Chua VS, Fernandez L, Quon D, Saralou A, Blackwelder WC, Hall FL, Gordon EM. Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1651-7. PMID 19532136 DOI: 10.1038/Mt.2009.126 |
0.01 |
|
| 2008 |
Chawla SP, Chua VS, Mohan V, Alzwahereh K, Kalra A, Quon D, Gordon EM, Hall FL. Phase I/II study of targeted gene delivery in vivo-intravenous infusions of Rexin-G-demonstrate significant biologic activity by FDG PET-CT without toxicity in patients with progressive chemo-resistant sarcoma, breast cancer and pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 14509. PMID 27950784 DOI: 10.1200/Jco.2008.26.15_Suppl.14509 |
0.01 |
|
| 2008 |
Cornelio GH, Lorenzo CC, Lopez FF, Hall FL, Gordon EM. Phase I study of sequential targeted gene delivery: Intravenous infusions of Rexin-G followed by Reximmune-C induce tumor necrosis and recruitment of tumor infiltrating lymphocytes in cancerous lesions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3077. PMID 27947690 DOI: 10.1200/Jco.2008.26.15_Suppl.3077 |
0.01 |
|
| 2008 |
Gordon EM, Levy JP, Reed RA, Petchpud WN, Liu L, Wendler CB, Hall FL. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ. International Journal of Oncology. 33: 665-75. PMID 18813779 DOI: 10.3892/Ijo_00000052 |
0.01 |
|
| 2007 |
Gordon EM, Chan MT, Geraldino N, Lopez FF, Cornelio GH, Lorenzo CC, Levy JP, Reed RA, Liu L, Hall FL. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes. International Journal of Oncology. 30: 1297-307. PMID 17487349 DOI: 10.3892/Ijo.30.6.1297 |
0.01 |
|
| 2006 |
Gordon EM, Lopez FF, Cornelio GH, Lorenzo CC, Levy JP, Reed RA, Liu L, Bruckner HW, Hall FL. Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience. International Journal of Oncology. 29: 1053-64. PMID 17016635 DOI: 10.3892/Ijo.29.5.1053 |
0.01 |
|
| 2005 |
Gordon EM, Hall FL. Nanotechnology blooms, at last (Review). Oncology Reports. 13: 1003-7. PMID 15870914 DOI: 10.3892/Or.13.6.1003 |
0.01 |
|
| 2004 |
Alauddin MM, Shahinian A, Gordon EM, Conti PS. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Molecular Imaging. 3: 76-84. PMID 15296672 DOI: 10.1162/1535350041464900 |
0.01 |
|
| 2004 |
Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H, Gazit-Bornstein G, Gordon EM, Gomer C, Hall FL, Gambhir SS, Lee AS. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Human Gene Therapy. 15: 553-61. PMID 15212714 DOI: 10.1089/104303404323142006 |
0.01 |
|
| 2004 |
Weiner LP, Louie KA, Atalla LR, Kochounian HH, Du J, Wei W, Hinton DR, Gordon EM, Anderson WF, McMillan M. Gene therapy in a murine model for clinical application to multiple sclerosis. Annals of Neurology. 55: 390-9. PMID 14991817 DOI: 10.1002/Ana.10858 |
0.01 |
|
| 2004 |
Guibinga GH, Hall FL, Gordon EM, Ruoslahti E, Friedmann T. Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 76-84. PMID 14741780 DOI: 10.1016/J.Ymthe.2003.09.018 |
0.01 |
|
| 2004 |
Gordon EM, Cornelio GH, Lorenzo CC, Levy JP, Reed RA, Liu L, Hall FL. First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer. International Journal of Oncology. 24: 177-85. PMID 14654955 DOI: 10.3892/Ijo.24.1.177 |
0.01 |
|
| 2004 |
Gordon E, Pahre J, Fuchs M, Levy J, Hall F. Molecular Engineering of “Pathotropic” Targeting for Cancer Gene Therapy Bioprocessing Journal. 3: 21-26. DOI: 10.12665/J31.Gordon |
0.01 |
|
| 2004 |
Alauddin MM, Shahinian A, Gordon EM, Conti PS. Direct Comparison of Radiolabeled Probes FMAU, FHBG, and FHPG as PET Imaging Agents for HSV1-tk Expression in a Human Breast Cancer Model Molecular Imaging. 3: 153535002004031. DOI: 10.1162/15353500200403160 |
0.01 |
|
| 2002 |
Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Molecular Imaging. 1: 74-81. PMID 12920847 DOI: 10.1162/153535002320162723 |
0.01 |
|
| 2002 |
Lenz HJ, Anderson WF, Hall FL, Gordon EM. Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic to liver. Human Gene Therapy. 13: 1515-37. PMID 12215272 DOI: 10.1089/10430340260185148 |
0.01 |
|
| 2002 |
Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of 2′-Deoxy-2′-Flouro-5-Methyl-1-β-d-Arabinofuranosyluracil as a Potential Gene Imaging Agent for HSV-tk Expression In Vivo Molecular Imaging. 1: 153535002002021. DOI: 10.1162/15353500200202100 |
0.01 |
|
| 2001 |
Masood R, Gordon EM, Whitley MD, Wu BW, Cannon P, Evans L, Anderson WF, Gill P, Hall FL. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors. International Journal of Molecular Medicine. 8: 335-43. PMID 11562769 DOI: 10.3892/Ijmm.8.4.335 |
0.01 |
|
| 2001 |
Gordon EM, Zhu NL, Forney Prescott M, Chen ZH, Anderson WF, Hall FL. Lesion-targeted injectable vectors for vascular restenosis. Human Gene Therapy. 12: 1277-87. PMID 11440621 DOI: 10.1089/104303401750270931 |
0.01 |
|
| 2001 |
Xu F, Prescott MF, Liu PX, Chen ZH, Liau G, Gordon EM, Hall FL. Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 construct. International Journal of Molecular Medicine. 8: 19-30. PMID 11408944 DOI: 10.3892/Ijmm.8.1.19 |
0.01 |
|
| 2001 |
Hall FL, Han B, Kundu RK, Yee A, Nimni ME, Gordon EM. Phenotypic differentiation of TGF-beta1-responsive pluripotent premesenchymal prehematopoietic progenitor (P4 stem) cells from murine bone marrow. Journal of Hematotherapy & Stem Cell Research. 10: 261-71. PMID 11359673 DOI: 10.1089/15258160151134962 |
0.01 |
|
| 2001 |
Gordon EM, Chen ZH, Liu L, Whitley M, Liu L, Wei D, Groshen S, Hinton DR, Anderson WF, Beart RW, Hall FL. Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice. Human Gene Therapy. 12: 193-204. PMID 11177556 DOI: 10.1089/104303401750061258 |
0.01 |
|
| 2000 |
Hall FL, Kaiser A, Liu L, Chen ZH, Hu J, Nimni ME, Beart RW, Gordon EM. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis. International Journal of Molecular Medicine. 6: 635-43. PMID 11078822 DOI: 10.3892/Ijmm.6.6.635 |
0.01 |
|
| 2000 |
Hall FL, Liu L, Zhu NL, Stapfer M, Anderson WF, Beart RW, Gordon EM. Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor. Human Gene Therapy. 11: 983-93. PMID 10811227 DOI: 10.1089/10430340050015293 |
0.01 |
|
| 2000 |
Liu L, Anderson WF, Beart RW, Gordon EM, Hall FL. Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells. Journal of Virology. 74: 5320-8. PMID 10799609 DOI: 10.1128/Jvi.74.11.5320-5328.2000 |
0.01 |
|
| 2000 |
Kampmeier J, Behrens A, Wang Y, Yee A, Anderson WF, Hall FL, Gordon EM, McDonnell PJ. Inhibition of rabbit keratocyte and human fetal lens epithelial cell proliferation by retrovirus-mediated transfer of antisense cyclin G1 and antisense MAT1 constructs. Human Gene Therapy. 11: 1-8. PMID 10646634 DOI: 10.1089/10430340050016102 |
0.01 |
|
| 2000 |
Wu KJ, Yee A, Zhu NL, Gordon EM, Hall FL. Characterization of differential gene expression in monkey arterial neointima following balloon catheter injury. International Journal of Molecular Medicine. 6: 433-473. DOI: 10.3892/Ijmm.6.4.433 |
0.01 |
|
| 2000 |
Behrens A, Kampmeier J, Liu PX, Li L, Wang Y, Yee A, Anderson WF, Hall FL, Gordon EM, McDonnell PJ. Inhibition Of Rabbit Keratocyte Cell Proliferation By Retrovirus-Mediated Transfer Of Antisense Cyclin G1 And Antisense Mat1 Constructs To Prevent Corneal Haze Development After Photorefractive/Phototherapeutic Keratectomy. Cornea. 19. DOI: 10.1097/00003226-200011002-00016 |
0.01 |
|
| 1999 |
Alauddin MM, Shahinian A, Kundu RK, Gordon EM, Conti PS. Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nuclear Medicine and Biology. 26: 371-6. PMID 10382839 DOI: 10.1016/S0969-8051(98)00116-4 |
0.01 |
|
| 1998 |
Seitz B, Baktanian E, Gordon EM, Anderson WF, LaBree L, McDonnell PJ. Retroviral vector-mediated gene transfer into keratocytes: in vitro effects of polybrene and protamine sulfate. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fã¼R Klinische Und Experimentelle Ophthalmologie. 236: 602-12. PMID 9717657 DOI: 10.1007/s004170050129 |
0.01 |
|
| 1998 |
Murata T, Hoffmann S, Ishibashi T, Spee C, Gordon EM, Anderson WF, Hinton DR, Ryan SJ. Retrovirus-mediated gene transfer targeted to retinal photocoagulation sites. Diabetologia. 41: 500-6. PMID 9628265 DOI: 10.1007/S001250050938 |
0.01 |
|
| 1998 |
Weimin Wu B, Cannon PM, Gordon EM, Hall FL, Anderson WF. Characterization of the proline-rich region of murine leukemia virus envelope protein. Journal of Virology. 72: 5383-91. PMID 9620992 DOI: 10.1128/Jvi.72.7.5383-5391.1998 |
0.01 |
|
| 1998 |
Sakamoto T, Spee C, Scuric Z, Gordon EM, Hinton DR, Anderson WF, Ryan SJ. Ability of retroviral transduction to modify the angiogenic characteristics of RPE cells. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fã¼R Klinische Und Experimentelle Ophthalmologie. 236: 220-9. PMID 9541827 DOI: 10.1007/S004170050068 |
0.01 |
|
| 1997 |
Misawa T, Chiang MH, Pandit L, Gordon EM, Anderson WF, Parekh D. Development of systemic immunologic responses against hepatic metastases during gene therapy for peritoneal carcinomatosis with retroviral HS-tk and ganciclovir. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 1: 527-33. PMID 9834388 DOI: 10.1016/S1091-255X(97)80069-8 |
0.01 |
|
| 1997 |
Hall FL, Gordon EM, Wu L, Zhu NL, Skotzko MJ, Starnes VA, Anderson WF. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein. Human Gene Therapy. 8: 2183-92. PMID 9449372 DOI: 10.1089/Hum.1997.8.18-2183 |
0.01 |
|
| 1997 |
Chen DS, Zhu NL, Hung G, Skotzko MJ, Hinton DR, Tolo V, Hall FL, Anderson WF, Gordon EM. Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice. Human Gene Therapy. 8: 1667-74. PMID 9322869 DOI: 10.1089/Hum.1997.8.14-1667 |
0.01 |
|
| 1997 |
Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson WF, Hall FL. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Human Gene Therapy. 8: 1385-94. PMID 9295133 DOI: 10.1089/Hum.1997.8.11-1385 |
0.01 |
|
| 1997 |
Zhu NL, Wu L, Liu PX, Gordon EM, Anderson WF, Starnes VA, Hall FL. Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation. Circulation. 96: 628-35. PMID 9244236 DOI: 10.1161/01.Cir.96.2.628 |
0.01 |
|
| 1997 |
Schubert CA, Kimura H, Spee C, Hinton DR, Gordon EM, Anderson WF, Ryan SJ. Retrovirus-mediated transfer of the suicide gene into retinal pigment epithelial cells in vitro. Current Eye Research. 16: 656-62. PMID 9222082 DOI: 10.1076/ceyr.16.7.656.5066 |
0.01 |
|
| 1996 |
Kimura H, Sakamoto T, Cardillo JA, Spee C, Hinton DR, Gordon EM, Anderson WF, Ryan SJ. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy. Human Gene Therapy. 7: 799-808. PMID 8860832 DOI: 10.1089/Hum.1996.7.7-799 |
0.01 |
|
| 1996 |
Gordon EM, Venkatesan N, Salazar R, Tang H, Schmeidler-Sapiro K, Buckley S, Warburton D, Hall FL. Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proceedings of the National Academy of Sciences of the United States of America. 93: 2174-9. PMID 8700904 DOI: 10.1073/Pnas.93.5.2174 |
0.01 |
|
| 1995 |
Sakamoto T, Kimura H, Scuric Z, Spee C, Gordon EM, Hinton DR, Anderson WF, Ryan SJ. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy? Ophthalmology. 102: 1417-24. PMID 9097787 DOI: 10.1016/S0161-6420(95)30850-0 |
0.01 |
|
| 1995 |
Hao QL, Malik P, Salazar R, Tang H, Gordon EM, Kohn DB. Expression of biologically active human factor IX in human hematopoietic cells after retroviral vector-mediated gene transduction. Human Gene Therapy. 6: 873-80. PMID 7578406 DOI: 10.1089/Hum.1995.6.7-873 |
0.01 |
|
| 1993 |
Gordon EM, Tang H, Salazar RL, Kohn DB. Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transfer. The American Journal of Pediatric Hematology/Oncology. 15: 196-203. PMID 8388667 DOI: 10.1097/00043426-199305000-00007 |
0.01 |
|
| 1988 |
Schacter L, Warth JA, Gordon EM, Prasad A, Klein BL. Altered amount and activity of superoxide dismutase in sickle cell anemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 2: 237-43. PMID 3350236 DOI: 10.1096/fasebj.2.3.3350236 |
0.01 |
|
| 1988 |
Coccia P, Strandjord S, Warkentin P, Cheung N, Gordon E, Novak L, Shina D, Herzig R. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission Blood. 71: 888-893. DOI: 10.1182/BLOOD.V71.4.888.BLOODJOURNAL714888 |
0.01 |
|
| 1988 |
Coccia P, Strandjord S, Warkentin P, Cheung N, Gordon E, Novak L, Shina D, Herzig R. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission Blood. 71: 888-893. DOI: 10.1182/blood.v71.4.888.888 |
0.01 |
|
| 1985 |
Sorensen RU, Newman AJ, Gordon EM. Psychogenic purpura in adolescent patients. Clinical Pediatrics. 24: 700-4. PMID 4064457 DOI: 10.1177/000992288502401206 |
0.01 |
|
| 1985 |
Schacter LP, DelVillano BC, Gordon EM, Klein BL. Red cell superoxide dismutase and sickle cell anemia symptom severity. American Journal of Hematology. 19: 137-44. PMID 4003385 |
0.01 |
|
| 1985 |
Gordon EM, Klein BL, Berman BW, Strandjord SE, Simon JE, Coccia PF. Reduction of contact factors in sickle cell disease. The Journal of Pediatrics. 106: 427-30. PMID 3844465 DOI: 10.1016/S0022-3476(85)80669-7 |
0.01 |
|
| 1985 |
Gordon EM, Klein BL, Berman BW, Strandford SE, Simon JE, Coccia PF. 910 EVIDENCE FOR REDUCTION OF CONTACT FACTORS IN SICKLE CELL DISEASE Pediatric Research. 19: 262A-262A. DOI: 10.1203/00006450-198504000-00940 |
0.01 |
|
| 1984 |
Odom L, Gordon E. Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin Blood. 64: 875-882. DOI: 10.1182/BLOOD.V64.4.875.BLOODJOURNAL644875 |
0.01 |
|
| 1984 |
Lazarus H, Coccia P, Herzig R, Graham-Pole J, Gross S, Strandjord S, Gordon E, Cheung N, Warkentin P, Spitzer T. Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients Blood. 64: 215-220. DOI: 10.1182/BLOOD.V64.1.215.215 |
0.01 |
|
| 1983 |
Gordon EM, Berkowitz RJ, Strandjord SE, Kurczynski EM, Goldberg JS, Coccia PF. Burkitt lymphoma in a patient with classic hemophilia receiving factor VIII concentrates. The Journal of Pediatrics. 103: 75-7. PMID 6408236 DOI: 10.1016/S0022-3476(83)80780-X |
0.01 |
|
| 1983 |
Lazarus HM, Herzig RH, Graham-Pole J, Wolff SN, Phillips GL, Strandjord S, Hurd D, Forman W, Gordon EM, Coccia P. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 1: 359-67. PMID 6366139 DOI: 10.1200/JCO.1983.1.6.359 |
0.01 |
|
| 1982 |
Herzig RH, Lazarus HM, Graham-Pole J, Gross S, Coccia P, Gordon EM, Strandjord S, Phillips GL, Herzig GP. Bone marrow transplantation with high-dose cytosine arabinoside. Medical and Pediatric Oncology. 10: 235-8. PMID 6761567 DOI: 10.1002/MPO.2950100724 |
0.01 |
|
| Hide low-probability matches. |